SARS-CoV-2-IN-33 is an inhibitor of COVID-19. SARS-CoV-2-IN-3 exhibits good binding affinity (-8.0 Kcal/mole) for COVID-19 major protease (Mpro) (PDB ID: 6LU7). SARS-CoV-2-IN-33 exhibits good anti-proliferative effects on cancer cells. SSARS-CoV-2-IN-33 can be used to study cancer and COVID-19.
Marketplace OffersShowing from 10 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
6-8 weeks
Purity
-
$ 1,520.00
1
Supplier
ChemDivSC
Pack Size
Estimated Lead Time
3-5 weeks
Purity
-
$ 148.00
1
Supplier
Vitas-MSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 84.31
1
Supplier
ChembridgeSC
Pack Size
Estimated Lead Time
3-4 weeks
Purity
-
$ 99.03
1
Supplier
SpecsSC
Pack Size
Estimated Lead Time
2-3 weeks
Purity
-
$ 37.00
1
Supplier
InterBioScreenSC
Pack Size
Estimated Lead Time
3-5 weeks
Purity
95%
$ 73.00
1
Supplier
Princeton BioMolecal ResearchSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
Inquiry
1
Supplier
PharmeksSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 36.67
1
Supplier
TimTecSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 183.33
1
Supplier
TimTecSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
Inquiry
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.